> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 3 Bayesian Examples Added to Demonstration Project
- URL: https://www.fdaweb.com/3-bayesian-examples-added-to-demonstration-project/
- Published: 2024-06-13T12:00:00.000Z
- Updated: 2026-09-14T14:33:19.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5157174

CDER says it has added three examples of Bayesian statistical analysis plans to its Center for Clinical Trial Innovation Supplemental Analysis Demonstration Project Web page. An online [post](https://www.fda.gov/about-fda/cder-center-clinical-trial-innovation-c3ti/bayesian-supplemental-analysis-bsa-demonstration-project?utm%5Fmedium=email&utm%5Fsource=govdelivery) says the demonstration project “seeks to advance the understanding of Bayesian statistical methods and establish processes for integrating these approaches into clinical trial design in the future.” The three examples (with links) are:

- [Bayesian statistical plan for a parallel group trial with a continuous outcome](http://www.fda.gov/media/177732/download?attachment&ref=fdaweb.com);
- [statistical analysis plan for a supplemental Bayesian analysis: unification of evidence](http://www.fda.gov/media/178886/download?attachment&ref=fdaweb.com); and
- [Statistical analysis plan for Bayesian subgroup analysis: sharing of information across subgroups](http://www.fda.gov/media/178887/download?attachment&ref=fdaweb.com).